Confirm the actual breakdown listed on the COA before designing your protocol
If your health insurance company requires prior authorization, you and your medical provider will need to take some other steps before you can receive coverage
Clinical trials with GLP-1 receptor agonists consistently demonstrate significant weight loss, with higher doses (such as semaglutide 2.4 mg weekly) producing approximately 15% average weight loss in adults without diabetes in clinical trials (somewhat less in type 2 diabetes) when combined with lifestyle modification
Per valorizzarne pienamente le competenze sono necessari interventi organizzativi, tra cui una maggiore integrazione della consulenza nutrizionale nei percorsi terapeutici con GLP-1, sistemi di rimborso adeguati, collegamenti pi stretti con le reti territoriali che promuovono laccesso a unalimentazione sana e una formazione specifica sullimpiego delle nuove terapie farmacologiche
Serious allergic reactions could pose a problem for some individuals, potentially involving rashes or difficulty breathing
Neuropsychopharmacology 40 , 15691579 (2015)